OBJECTIVES: Increasing the level of transparency of decision-making process of reimbursement for drugs used in oncology by facilitating online access to public information and other information regarding the refund of cancer drugs in Poland compared to solutions used in the world. METHODS: The project will be developed a comprehensive system to monitor the transparency of reimbursement decision-making process in Poland, consisting of: Guidelines and Clinical and Reimbursement Recommendations Database (WiRKliR database) whose purpose is to collect documents from the Polish and selected countries of the clinical guidelines, registration and decisions about the recommendations and decisions regarding reimbursement for cancer drugs and present information contained in them in a comprehensible and transparent. Reimbursement monitoring which aims to carry out continuous monitoring of the implementation of law and regulation in the field of oncology drug reimbursement and the acquisition of complementary information about the cancer drugs in the database WiRKliR. Reimbursement reports whose purpose is to discuss the issue of transparency of reimbursement through the analysis of procedures drawn up and applied by public authorities in dealing with citizens, with special emphasis on patients and pharmaceutical companies in the reimbursement decision-making process and to present the results of the various stages of our work. RESULTS: The most important results of the project include: increased transparency of institutions involved in the drug reimbursement decision-making process, the democratization of medical information, provide decision-makers Polish health care system expertise, to increase patient awareness about their rights and proposals for corrective actions (conclusions and recommendations) for public administration in the area of the refund. CONCLUSIONS: A comprehensive monitoring system for civil funding allocation process in the health care system to counteract the imbalance of information.